GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC – News), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that is has been issued U.S. Patent 7,422,605,B2 for its rotating bearing knee prosthesis, Optetrak® RBK™.
Exactech’s Optetrak RBK knee has been an important part of the company’s total knee business outside the U.S., particularly in Europe, where rotating bearing knee designs are popular. Since 2006, Exactech has sponsored a U.S. Investigational Device Exemption (IDE) clinical trial for Optetrak RBK, which will support its future submission of a Premarket Approval (PMA) application to the U.S. Food and Drug Administration.
